FDA Inspection 1264654 — Alejandro E. De La Cruz, M.D.

Alejandro E. De La Cruz, M.D. — FEI 3031133747

The FDA completed an inspection of Alejandro E. De La Cruz, M.D. on March 18, 2025 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)